$COOP
Mr. Cooper Group Inc.

2018 Q2 Form 10-Q Financial Statement

#000156459018017756 Filed on July 27, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q4 2017 Q2
Revenue $444.0M $1.961M $2.032M
YoY Change 21750.39% 60.34% 46.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $666.3M $8.500M $1.800M
YoY Change 36916.67% 286.36% 20.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.00M
YoY Change
% of Gross Profit
Operating Expenses $339.0M $8.000M $1.900M
YoY Change 17742.11% 788.89% 11.76%
Operating Profit -$1.996M $4.058M
YoY Change -149.19%
Interest Expense $164.0M -$3.000M $599.0K
YoY Change 27278.96% -102.14% -97.37%
% of Operating Profit 14.76%
Other Income/Expense, Net -$26.00M $0.00
YoY Change -100.0%
Pretax Income $79.00M -$9.000M -$21.30M
YoY Change -470.89% -106.41% -195.09%
Income Tax $21.00M $0.00 $0.00
% Of Pretax Income 26.58%
Net Earnings $58.00M -$9.000M -$21.32M
YoY Change -371.99% -106.41% -195.2%
Net Earnings / Revenue 13.06% -458.95% -1049.41%
Basic Earnings Per Share $0.59 -$0.07 -$0.13
Diluted Earnings Per Share $0.59 -$0.07 -$0.13
COMMON SHARES
Basic Shares Outstanding 98.20M shares 202.6M
Diluted Shares Outstanding 99.13M shares 202.6M

Balance Sheet

Concept 2018 Q2 2017 Q4 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $185.0M $27.00M $36.00M
YoY Change 413.89% 1250.0% 800.0%
Cash & Equivalents $185.0M $215.0M $611.5M
Short-Term Investments $0.00
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.00M $27.00M $36.00M
YoY Change -19.44% 1250.0% 800.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.000M $8.000M $32.00M
YoY Change -96.88% -89.87% -64.84%
Other Assets $576.0M $579.0M $575.0M
YoY Change 0.17% 1.05% 0.35%
Total Long-Term Assets $17.16B $18.01B $681.0M
YoY Change 2419.97% 2353.54% 2.51%
TOTAL ASSETS
Total Short-Term Assets $29.00M $27.00M $36.00M
Total Long-Term Assets $17.16B $18.01B $681.0M
Total Assets $17.19B $18.04B $717.0M
YoY Change 2297.49% 2350.54% 7.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $18.00M
YoY Change -100.0% -100.0% -10.0%
Other Long-Term Liabilities $21.00M $17.00M $14.00M
YoY Change 50.0% -19.05% -78.79%
Total Long-Term Liabilities $21.00M $17.00M $32.00M
YoY Change -34.38% -57.5% -62.79%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $21.00M $17.00M $32.00M
Total Liabilities $20.86M $16.82M $32.90M
YoY Change -36.6% -57.96% -62.18%
SHAREHOLDERS EQUITY
Retained Earnings $72.84M $93.55M
YoY Change 9.14%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.99M $93.59M $684.0M
YoY Change
Total Liabilities & Shareholders Equity $610.6M $614.1M $717.0M
YoY Change -14.84% -16.58% 7.34%

Cashflow Statement

Concept 2018 Q2 2017 Q4 2017 Q2
OPERATING ACTIVITIES
Net Income $58.00M -$9.000M -$21.32M
YoY Change -371.99% -106.41% -195.2%
Depreciation, Depletion And Amortization $14.00M
YoY Change
Cash From Operating Activities -$2.000M $5.000M -$4.000M
YoY Change -50.0% 400.0% 33.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $4.000M $7.000M $25.00M
YoY Change -84.0% 16.67% 150.0%
Cash From Investing Activities $4.000M $7.000M $25.00M
YoY Change -84.0% 16.67% 150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -5.000M -5.000M
YoY Change -100.0% 0.0% 25.0%
NET CHANGE
Cash From Operating Activities -2.000M 5.000M -4.000M
Cash From Investing Activities 4.000M 7.000M 25.00M
Cash From Financing Activities 0.000 -5.000M -5.000M
Net Change In Cash 2.000M 7.000M 16.00M
YoY Change -87.5% 250.0% 433.33%
FREE CASH FLOW
Cash From Operating Activities -$2.000M $5.000M -$4.000M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29058000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
575779000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
578936000
CY2018Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
48000
CY2017Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
59000
CY2018Q2 us-gaap Other Assets
OtherAssets
4970000
CY2017Q4 us-gaap Other Assets
OtherAssets
558000
CY2018Q2 us-gaap Assets
Assets
610563000
CY2017Q4 us-gaap Assets
Assets
614121000
CY2018Q2 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
273000
us-gaap Net Income Loss
NetIncomeLoss
-7579000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202632883
CY2017Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
474000
us-gaap Net Income Loss
NetIncomeLoss
-3535000
CY2017Q4 us-gaap Unearned Premiums
UnearnedPremiums
39000
CY2018Q2 us-gaap Other Liabilities
OtherLiabilities
20586000
CY2017Q4 us-gaap Other Liabilities
OtherLiabilities
16303000
CY2017Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
4500000
CY2018Q2 us-gaap Liabilities
Liabilities
20859000
CY2017Q4 us-gaap Liabilities
Liabilities
16816000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
204386223
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
200000
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
9000000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
503713000
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
503713000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13150000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202529003
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72839000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
194136000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
25882000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
93551000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1996000
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25824000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7779000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12535000
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
85991000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
93592000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
610563000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
206061686
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
614121000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3500000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3500000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216664908
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
206714132
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202632883
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
204386223
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216664908
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
206714132
CY2018Q2 us-gaap Premiums Earned Net
PremiumsEarnedNet
18000
CY2017Q2 us-gaap Premiums Earned Net
PremiumsEarnedNet
329000
CY2017 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
18050000
CY2018Q2 us-gaap Net Investment Income
NetInvestmentIncome
3059000
CY2017Q2 us-gaap Net Investment Income
NetInvestmentIncome
1703000
us-gaap Net Investment Income
NetInvestmentIncome
5229000
us-gaap Net Investment Income
NetInvestmentIncome
2883000
CY2018Q2 us-gaap Revenues
Revenues
3077000
CY2017Q2 us-gaap Revenues
Revenues
2032000
us-gaap Revenues
Revenues
5270000
us-gaap Revenues
Revenues
3642000
CY2018Q2 wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
-135000
CY2017Q2 wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
65000
wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
-73000
wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
159000
CY2017Q2 us-gaap Insurance Commissions
InsuranceCommissions
43000
us-gaap Insurance Commissions
InsuranceCommissions
93000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5208000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1786000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12922000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3798000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206061686
CY2017Q2 wmih Gain Loss On Contract Fair Market Value Reserve
GainLossOnContractFairMarketValueReserve
4519000
wmih Gain Loss On Contract Fair Market Value Reserve
GainLossOnContractFairMarketValueReserve
5435000
CY2017Q2 us-gaap Interest Expense
InterestExpense
599000
us-gaap Interest Expense
InterestExpense
1209000
CY2018Q2 wmih Operating Expenses Benefits
OperatingExpensesBenefits
5073000
CY2017Q2 wmih Operating Expenses Benefits
OperatingExpensesBenefits
-2026000
wmih Operating Expenses Benefits
OperatingExpensesBenefits
12849000
wmih Operating Expenses Benefits
OperatingExpensesBenefits
-176000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1996000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4058000
CY2018Q2 wmih Cash Equivalents Held In Trust
CashEquivalentsHeldInTrust
708000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202529003
CY2018Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
708000
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
wmih Increase Decrease In Loss Contract Fair Market Value Reserve
IncreaseDecreaseInLossContractFairMarketValueReserve
5435000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7583000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-533000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1996000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-21324000
CY2017 wmih Adjustments To Additional Paid In Capital Reclassification Of Derivative Asset
AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeAsset
108893000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
517000
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
200000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
178000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
76000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-27000
us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
15000
us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
23000
us-gaap Share Based Compensation
ShareBasedCompensation
178000
us-gaap Share Based Compensation
ShareBasedCompensation
313000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-11000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-19000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4412000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-19000
wmih Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
-3491000
wmih Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
5327000
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-201000
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-123000
wmih Increase Decrease In Losses Payable
IncreaseDecreaseInLossesPayable
-53000
us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-39000
us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-235000
wmih Increase Decrease In Accrued Ceding Commission Expense
IncreaseDecreaseInAccruedCedingCommissionExpense
-9000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-5000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6607000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-3936000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-972000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7471000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
611508000
us-gaap Interest Paid Net
InterestPaidNet
1214000
us-gaap Stock Issued1
StockIssued1
12933000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19974000
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
3664000
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
72663000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3664000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
52689000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2500000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1000000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
9000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
548000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9548000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-808000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
35670000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
605645000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
575838000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
604837000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Management has made significant estimates in certain areas, including valuing certain financial instruments, other assets and liabilities, the determination of the contingent risk liabilities, and in determining appropriate insurance reserves. Actual results could differ substantially from those estimates. </p></div>
us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the liability for losses and loss adjustment reserves are as follows as of June 30, 2018 and December&#160;31, 2017, respectively: </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.4%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.5%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2018</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2017</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.4%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Case-basis reserves</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.4%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IBNR reserves</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.4%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premium deficiency reserves</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">322</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.4%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total losses and loss adjustment reserves</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">474</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div>
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q2 us-gaap Unearned Premiums
UnearnedPremiums
0
CY2018Q2 wmih Premium Deficiency Reserves
PremiumDeficiencyReserves
300000
CY2017Q4 wmih Premium Deficiency Reserves
PremiumDeficiencyReserves
300000
CY2018Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4600000
CY2018Q2 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
400000
CY2017Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
600000
us-gaap Plan Of Reorganization Dates Plan Is Effective
PlanOfReorganizationDatesPlanIsEffective
2012-03-19
wmih Expected Merger Closing Date
ExpectedMergerClosingDate
2018-07-31
CY2018Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
12300000
CY2017Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4700000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
wmih Amount Of Dividends Paid On Or After Effective Date
AmountOfDividendsPaidOnOrAfterEffectiveDate
0
CY2009Q3 wmih Quoted Percentage To Share Base
QuotedPercentageToShareBase
0.50
CY2018Q2 wmih Net Premiums Assumed Released
NetPremiumsAssumedReleased
18000
CY2017Q2 wmih Net Premiums Assumed Released
NetPremiumsAssumedReleased
319000
wmih Net Premiums Assumed Released
NetPremiumsAssumedReleased
2000
wmih Net Premiums Assumed Released
NetPremiumsAssumedReleased
524000
CY2017Q2 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-10000
CY2016Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
811000
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
-73000
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
128000
CY2018Q2 wmih Loss Contract Value Reserve Balance
LossContractValueReserveBalance
0
wmih Loss Contract Value Reserve Decrease
LossContractValueReserveDecrease
0
CY2018Q2 us-gaap Marketable Securities
MarketableSecurities
0
CY2017Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
3674000
CY2017 us-gaap Trading Securities Unrealized Holding Loss
TradingSecuritiesUnrealizedHoldingLoss
14000
CY2017Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
3660000
CY2018Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
6000
CY2017Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-25000
CY2018Q2 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
17000
CY2017Q2 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
2000
CY2018Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
3059000
CY2017Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
1703000
us-gaap Gain Loss On Investments
GainLossOnInvestments
5229000
us-gaap Gain Loss On Investments
GainLossOnInvestments
2883000
CY2018Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
28684000
CY2017Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
34440000
CY2018Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
2416000
CY2018Q2 wmih Percentage Of Valuation Allowance Applicable To Net Operating Loss
PercentageOfValuationAllowanceApplicableToNetOperatingLoss
1.00
CY2018Q2 wmih Percentage Of Valuation Allowance Applicable To Net Operating Loss To Be Reduced
PercentageOfValuationAllowanceApplicableToNetOperatingLossToBeReduced
0.00
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
wmih Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Assets Provisional Income Tax Benefit Relating To Net Operating Loss Carryforward
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetsProvisionalIncomeTaxBenefitRelatingToNetOperatingLossCarryforward
842900000
CY2018Q2 wmih Valuation Allowance Equal To Net Deferred Federal Income Tax Asset
ValuationAllowanceEqualToNetDeferredFederalIncomeTaxAsset
1.00
CY2017Q4 wmih Valuation Allowance Equal To Net Deferred Federal Income Tax Asset
ValuationAllowanceEqualToNetDeferredFederalIncomeTaxAsset
1.00
CY2012Q1 wmih Non Operating Loss Due To Abandonment Of Stock
NonOperatingLossDueToAbandonmentOfStock
8400000000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6000000000
wmih Net Operating Loss Expiration Date
NetOperatingLossExpirationDate
2031
wmih Capital Loss Carryforward Subject To Expiration Year
CapitalLossCarryforwardSubjectToExpirationYear
2018
CY2017 wmih Capital Loss Carryforward Subject To Expiration Year
CapitalLossCarryforwardSubjectToExpirationYear
2018
CY2018Q2 wmih Reserve For Uncertain Federal Income Tax Position
ReserveForUncertainFederalIncomeTaxPosition
0
CY2017 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2011
CY2018Q2 wmih Number Of Debt Financing Arrangements
NumberOfDebtFinancingArrangements
0
CY2017Q4 wmih Number Of Debt Financing Arrangements
NumberOfDebtFinancingArrangements
0
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3500000000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
61400000
wmih Class Of Warrant Or Right Warrants Expiration Period
ClassOfWarrantOrRightWarrantsExpirationPeriod
P5Y
CY2018Q1 wmih Warrants Issued To Purchase Of Common Stock
WarrantsIssuedToPurchaseOfCommonStock
61400000
wmih Registration Rights Agreement Blackout And Lockups Period
RegistrationRightsAgreementBlackoutAndLockupsPeriod
P180D
CY2018Q2 wmih Common Stock Issuable Shares
CommonStockIssuableShares
520158730
CY2015Q1 us-gaap Escrow Deposit
EscrowDeposit
598500000
CY2018Q2 us-gaap Escrow Deposit
EscrowDeposit
575800000
CY2017Q4 us-gaap Escrow Deposit
EscrowDeposit
578900000
us-gaap Business Acquisition Description Of Acquired Entity
BusinessAcquisitionDescriptionOfAcquiredEntity
“Acquisition” means any acquisition by the Company (or any of its direct or indirect wholly-owned subsidiaries), in a single transaction or a series of transactions, whether by purchase, merger or otherwise, of all or substantially all of the assets of, or of 80% or more of the equity interests in, or a business line, unit or division of, any person.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2017 wmih Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Reclassification Of Derivative Asset To Equity
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationReclassificationOfDerivativeAssetToEquity
-108893000
CY2018Q1 wmih Conversion Price Per Share Of Common Stock
ConversionPricePerShareOfCommonStock
1.35
wmih Additional Share Based Compensation Restricted Stock Awards Outstanding Restricted Stock Awards Granted
AdditionalShareBasedCompensationRestrictedStockAwardsOutstandingRestrictedStockAwardsGranted
1015872
CY2018Q2 wmih Share Based Compensation Unvested Restricted Awards Outstanding Unamortized
ShareBasedCompensationUnvestedRestrictedAwardsOutstandingUnamortized
5511000
CY2017Q4 wmih Share Based Compensation Unvested Restricted Awards Outstanding Unamortized
ShareBasedCompensationUnvestedRestrictedAwardsOutstandingUnamortized
3500000
CY2018Q2 wmih Share Based Compensation Unamortized Restricted Fair Value Awards Subject To Vesting Schedule
ShareBasedCompensationUnamortizedRestrictedFairValueAwardsSubjectToVestingSchedule
747000
CY2018Q2 wmih Share Based Compensation Unamortized Restricted Fair Value Dependent Awards Outstanding
ShareBasedCompensationUnamortizedRestrictedFairValueDependentAwardsOutstanding
4764000
wmih Repurchase Price Unvested Common Stock
RepurchasePriceUnvestedCommonStock
0.00001
CY2018Q2 wmih Warrants Issued To Purchase Of Common Stock
WarrantsIssuedToPurchaseOfCommonStock
61400000
CY2017Q4 wmih Warrants Issued To Purchase Of Common Stock
WarrantsIssuedToPurchaseOfCommonStock
61400000
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61400000
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61400000
CY2018Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0
CY2018Q2 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
May 8, 2018
us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
0
CY2017Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4500000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
200000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
9000000
CY2018Q2 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
-1996000
CY2017Q2 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
-25824000
wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
-7779000
wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
-12535000
CY2018Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
209902759
CY2017Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
206490690
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
208317254
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
206436048
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3841073
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3857807
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3931031
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3907045
CY2018Q2 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
-1996000
CY2017Q2 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
-25824000
wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
-7779000
wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
-12535000
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
84400000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21197619
CY2016Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
80651000
CY2017 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
28242000
CY2017 wmih Change In Fair Value Of Derivative Assets Recognized In Earnings
ChangeInFairValueOfDerivativeAssetsRecognizedInEarnings
28200000
CY2017 wmih Fair Market Value Of Derivative Liability Transferred To Equity
FairMarketValueOfDerivativeLiabilityTransferredToEquity
108900000

Files In Submission

Name View Source Status
0001564590-18-017756-index-headers.html Edgar Link pending
0001564590-18-017756-index.html Edgar Link pending
0001564590-18-017756.txt Edgar Link pending
0001564590-18-017756-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wmih-10q_20180630.htm Edgar Link pending
wmih-20180630.xml Edgar Link completed
wmih-20180630.xsd Edgar Link pending
wmih-20180630_cal.xml Edgar Link unprocessable
wmih-20180630_def.xml Edgar Link unprocessable
wmih-20180630_lab.xml Edgar Link unprocessable
wmih-20180630_pre.xml Edgar Link unprocessable
wmih-ex121_8.htm Edgar Link pending
wmih-ex311_6.htm Edgar Link pending
wmih-ex312_9.htm Edgar Link pending
wmih-ex321_7.htm Edgar Link pending